Hypoglycemia Associated With Drug-Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors

• Autori principali: Chin-Ying Ray (Autore), Victor Chien-Chia Wu (Autore), Chun-Li Wang (Autore), Hui-Tzu Tu (Autore), Yu-Tung Huang (Autore), Chang-Fu Kuo (Autore), Shang-Hung Chang (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Dipeptidylpeptidase-4 inhibitors (DPP-4i's) are considered to be safe for patients with type 2 diabetes mellitus (T2DM). However, little is known about drug-drug interactions between DPP-4i's and concurrent medications.Methods: Data on patients using DPP-4i's for T2DM duri...